India to Philippines: Amikacin Export Trade Route
India has recorded 59 verified shipments of Amikacin exported to Philippines, representing a combined trade value of $518.6K USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $8.8K USD. The leading Indian exporter is SCOTT EDIL PHARMACIA LIMITED, which accounts for 26% of total export value with 25 shipments worth $135.3K USD. On the buying side, PHIL PHARMA WEALTH, INC. is the largest importer in Philippines with $97.9K USD in purchases. The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED, KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED, KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Amikacin corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $518.6K USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's amikacin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $8.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with amikacin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 17.8%, placing it at rank #13 among India's top amikacin export destinations globally.
On the import side, key buyers of Indian amikacin in Philippines include PHIL PHARMA WEALTH, INC. , PHIL PHARMA WEALTH, INC., TO THE DIRECTOR OF and 15 others. PHIL PHARMA WEALTH, INC. is the single largest importer with 5 shipments valued at $97.9K USD.
